Walkey Carl

Track

Insider profile

Walkey Carl's trades of Neurogene Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-06-17 2021-06-16
US Neurogene Inc (NGNE)
PlS Planned sale
32,720 -14.9%
13.39
US$2,571,905 		32,720 -14.9% 13.39 US$2,571,905
2021-06-11 2021-06-09
US Neurogene Inc (NGNE)
PlS Planned sale
18,695 -33.7%
321.77
US$3,513,534 		18,695 -33.7% 321.77 US$3,513,534
2021-06-09 2021-06-08
US Neurogene Inc (NGNE)
PlS Planned sale
82,803 +16.4%
281.30
US$2,851,749 		82,803 +16.4% 281.30 US$2,851,749
2021-05-26 2021-05-26
US Neurogene Inc (NGNE)
PlS Planned sale
600 -0.0%
10.00
US$6,000 		600 -0.0% 10.00 US$6,000
2021-05-21 2021-05-19
US Neurogene Inc (NGNE)
PlS Planned sale
600 -0.0%
10.63
US$6,378 		600 -0.0% 10.63 US$6,378
2021-05-12 2021-05-12
US Neurogene Inc (NGNE)
PlS Planned sale
1,200 -0.1%
11.09
US$13,308 		1,200 -0.1% 11.09 US$13,308
2021-05-06 2021-05-05
US Neurogene Inc (NGNE)
PlS Planned sale
1,200 -0.1%
11.30
US$13,560 		1,200 -0.1% 11.30 US$13,560
2021-04-30 2021-04-28
US Neurogene Inc (NGNE)
PlS Planned sale
2,400 -0.2%
12.58
US$30,192 		2,400 -0.2% 12.58 US$30,192
2021-04-27 2021-04-26
US Neurogene Inc (NGNE)
PlS Planned sale
600 -0.0%
13.00
US$7,800 		600 -0.0% 13.00 US$7,800
2021-04-22 2021-04-21
US Neurogene Inc (NGNE)
PlS Planned sale
1,800 -0.1%
11.98
US$21,564 		1,800 -0.1% 11.98 US$21,564
2021-04-16 2021-04-14
US Neurogene Inc (NGNE)
PlS Planned sale
1,800 -0.1%
12.22
US$21,996 		1,800 -0.1% 12.22 US$21,996
2021-04-08 2021-04-07
US Neurogene Inc (NGNE)
PlS Planned sale
1,800 -0.1%
12.02
US$21,636 		1,800 -0.1% 12.02 US$21,636
2021-04-06 2021-04-05
US Neurogene Inc (NGNE)
PlS Planned sale
600 -0.0%
13.00
US$7,800 		600 -0.0% 13.00 US$7,800
2021-04-02 2021-03-31
US Neurogene Inc (NGNE)
PlS Planned sale
1,800 -0.1%
11.96
US$21,528 		1,800 -0.1% 11.96 US$21,528
2021-03-24 2021-03-24
US Neurogene Inc (NGNE)
PlS Planned sale
1,800 -0.1%
11.95
US$21,516 		1,800 -0.1% 11.95 US$21,516
2021-03-24 2021-03-22
US Neurogene Inc (NGNE)
PlS Planned sale
600 -0.0%
12.00
US$7,200 		600 -0.0% 12.00 US$7,200
2021-03-18 2021-03-17
US Neurogene Inc (NGNE)
PlS Planned sale
1,200 -0.1%
11.36
US$13,632 		1,200 -0.1% 11.36 US$13,632
2021-03-11 2021-03-10
US Neurogene Inc (NGNE)
PlS Planned sale
1,800 -0.1%
11.97
US$21,540 		1,800 -0.1% 11.97 US$21,540
2021-03-04 2021-03-03
US Neurogene Inc (NGNE)
PlS Planned sale
1,800 -0.1%
11.87
US$21,360 		1,800 -0.1% 11.87 US$21,360
2021-02-25 2021-02-25
US Neurogene Inc (NGNE)
PlS Planned sale
600 -0.0%
13.00
US$7,800 		600 -0.0% 13.00 US$7,800
2021-02-25 2021-02-24
US Neurogene Inc (NGNE)
PlS Planned sale
1,800 -0.1%
12.14
US$21,852 		1,800 -0.1% 12.14 US$21,852
2021-02-18 2021-02-17
US Neurogene Inc (NGNE)
PlS Planned sale
2,400 -0.2%
12.70
US$30,480 		2,400 -0.2% 12.70 US$30,480
2021-02-12 2021-02-10
US Neurogene Inc (NGNE)
PlS Planned sale
3,000 -0.2%
14.20
US$42,600 		3,000 -0.2% 14.20 US$42,600
2021-02-09 2021-02-05
US Neurogene Inc (NGNE)
PlS Planned sale
600 -0.0%
14.00
US$8,400 		600 -0.0% 14.00 US$8,400
2021-02-05 2021-02-03
US Neurogene Inc (NGNE)
PlS Planned sale
2,400 -0.2%
13.23
US$31,752 		2,400 -0.2% 13.23 US$31,752